KWALITY PHARMACEUTICALS L Share Price

KWALITY PHARMACEUTICALS L Share Price

NSE: KPL
|
Pharmaceuticals
|
S Cap
₹ 2,611.80
-₹40.30 (-1.52%)
1D
Last updated 07 Aug, 2026, 15:29 IST

KWALITY PHARMACEUTICALS L Share Price Today

As of 9 Aug 2026, KWALITY PHARMACEUTICALS L share price is ₹2,611.80. The stock opened at ₹2,664.90, compared to its previous close of ₹2,652.10. During today's trading session, KWALITY PHARMACEUTICALS L share price moved in the range of ₹2,490.40 to ₹2,709.00, with an average price of ₹2,599.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,561.00 and a high of ₹2,890.30. On the performance front, KWALITY PHARMACEUTICALS L share price has increased by 61.07% over the last six months and is up 61.07% on a year-on-year basis.

₹2,490.40
1.52% down today
₹2,709.00
1D LOW
1D HIGH

KWALITY PHARMACEUTICALS L Returns Calculator

Circuit
L
H
₹2,089.50
₹3,134.10
52-week
L
H
₹1,561.00
₹2,890.30

About KWALITY PHARMACEUTICALS L

KWALITY PHARMACEUTICALS L Share Price
ISIN
INE552U01010
Sector Market Cap
₹ 2,707.2 Cr

Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.

KWALITY PHARMACEUTICALS L Financial Highlights

  • Revenue: KWALITY PHARMACEUTICALS L reported revenue of ₹505.94 crore in FY26 vs ₹372.12 crore in FY25. It showed an increase of 35.96% on a yearly basis.
  • Operating Profit: KWALITY PHARMACEUTICALS L reported an operating profit of ₹89.49 crore in FY26 vs ₹54.14 crore in FY25. It showed an increase of 65.29% on a year-on-year basis.
  • Net Profit: KWALITY PHARMACEUTICALS L reported a net profit of ₹67.35 crore in FY26 vs ₹39.80 crore in FY25. It showed an increase of 69.22% on a yearly basis.

KWALITY PHARMACEUTICALS L Quarterly Result Highlights

  • KWALITY PHARMACEUTICALS L reported revenue of ₹158.17 crore in Mar 2026, compared with ₹123.97 crore in Dec 2025, representing an increase of 27.59% on a quarter-on-quarter (QoQ) basis.
  • KWALITY PHARMACEUTICALS L reported an operating profit of ₹31.67 crore in Mar 2026, compared with ₹22.35 crore in Dec 2025, representing an increase of 41.70% on a quarter-on-quarter (QoQ) basis.
  • KWALITY PHARMACEUTICALS L reported a profit of ₹25.31 crore in Mar 2026, compared with ₹16.00 crore in Dec 2025, reflecting an increase of 58.19% on a QoQ basis.
  • The earnings per share (EPS) of KWALITY PHARMACEUTICALS L stood at ₹38.36 during Mar 2026.
Know more
Promoters
54.86%
FII
3.13%
Other DII
0.56%
Retail and other
41.44%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.50%
Mar 20262.79%
Jun 20263.13%
Mkt Cap Cr
2,707.20
P/E
40.20
P/B
8.18
ROE
20.31%
D/E
0.39
ROCE
21.46%
Div. Yield
0.00%
EPS(TTM)
64.90
Turnover
1.36
EV/EBITDA
23.94
Net Margin
0.00%
Op. Margin
0.00%
ROA
11.37%
Quick Ratio
0.00
Curr. Ratio
3.27
Based on fundamentals, this stock's
Step 2 of 5
Performance
Poor
Kwality Pharma has underperformed the market
Step 1 of 5
Valuation
Overvalued
Kwality Pharma appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Kwality Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,67,630.0038.595.6013.74%0.6117.33%93.240.82%0.4810.90
Divis Laboratories2,18,972.0074.8613.0615.32%0.0019.56%629.490.36%0.5598.19
Torrent Pharmaceuticals1,88,358.0087.3722.4025.49%1.6913.85%222.760.68%0.4958.70
Cipla1,18,915.0035.443.4511.27%0.0014.95%423.360.88%0.4543.52
Zydus Lifesciences1,11,242.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,07,907.0019.444.8123.76%0.0424.88%659.050.76%0.57129.18
Mankind Pharma1,00,730.0048.726.1811.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs1,00,228.0091.9218.9116.77%0.4016.14%97.200.11%0.6713.72
Dr. Reddy's Laboratories97,824.0030.732.5711.07%0.1812.54%377.960.68%0.4138.68
Aurobindo Pharma96,471.1026.002.559.25%0.1911.76%391.140.24%0.3841.58

KWALITY PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹370.20₹307.17₹251.03₹456.19
Other Income₹1.92₹1.83₹2.94₹3.51
Total Revenue₹372.12₹309.00₹253.97₹459.70
Total Expenses₹317.98₹270.80₹211.87₹298.13
Profit Before Tax₹54.14₹31.10₹25.57₹161.57
Tax₹14.34₹7.48₹6.29₹41.63
Profit After Tax₹39.80₹23.62₹19.28₹119.94
EPS - Basic₹38.36₹22.76₹18.16₹115.12
EPS - Diluted₹38.36₹22.76₹18.16₹115.12

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹54.14₹31.10₹25.57₹161.57
Income before WC changes₹82.14₹67.72₹46.52₹175.13
Change in Assets-₹31.33-₹41.49₹14.55-₹118.64
Change in Liabilities₹17.69₹18.06-₹13.54₹45.47
Change in WC-₹13.64-₹23.44₹1.01-₹73.18
Cash flow from Operations₹52.72₹42.98₹41.38₹60.60
Cash flow from Investing-₹28.52-₹26.40-₹48.44-₹62.93
Cash flow from Financing-₹14.44-₹17.40₹0.99₹5.66
Total Cash Flow₹9.76-₹0.81-₹6.07₹3.33
Cash (Start of the year)₹2.26₹3.07₹9.13₹5.81
Cash (End of the year)₹12.02₹2.26₹3.07₹9.13

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹163.49₹151.52₹146.43₹112.77
Current Assets₹283.78₹242.69₹207.20₹227.82
Total Assets₹447.27₹394.21₹353.63₹340.59
Current Liabilities₹169.51₹151.85₹125.95₹139.49
Net Current Asset₹114.27₹90.84₹81.25₹88.33
Non-Current Liabilities₹15.37₹19.78₹28.62₹21.32
Equity Capital₹262.40₹222.58₹199.07₹179.79
Total Equity & Liabilities₹447.27₹394.21₹353.63₹340.59

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹370.20₹307.17₹250.99₹456.13
Other Income₹1.92₹1.83₹2.94₹3.51
Total Revenue₹372.12₹309.00₹253.94₹459.64
Total Expenses₹317.89₹270.44₹211.65₹297.97
Profit Before Tax₹54.23₹31.47₹25.76₹161.67
Tax₹14.34₹7.48₹6.29₹41.63
Profit After Tax₹39.89₹23.98₹19.47₹120.05
EPS - Basic₹38.44₹23.11₹18.45₹115.36
EPS - Diluted₹38.44₹23.11₹18.45₹115.36

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹54.23₹31.47₹25.76₹161.67
Income before WC changes₹82.20₹68.08₹46.67₹175.19
Change in Assets-₹31.33-₹41.49₹14.54-₹119.51
Change in Liabilities₹17.69₹18.07-₹12.86₹44.92
Change in WC-₹13.64-₹23.43₹1.67-₹74.59
Cash flow from Operations₹52.77₹43.35₹42.19₹59.24
Cash flow from Investing-₹28.13-₹26.40-₹48.44-₹62.98
Cash flow from Financing-₹14.44-₹17.40₹0.99₹5.66
Total Cash Flow₹10.20-₹0.45-₹5.26₹1.93
Cash (Start of the year)₹1.35₹1.80₹7.06₹5.13
Cash (End of the year)₹11.55₹1.35₹1.80₹7.06

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹165.82₹154.19₹149.06₹115.36
Current Assets₹284.90₹243.38₹207.52₹227.32
Total Assets₹450.72₹397.57₹356.58₹342.68
Current Liabilities₹169.51₹151.85₹125.94₹138.80
Net Current Asset₹115.40₹91.53₹81.58₹88.51
Non-Current Liabilities₹15.37₹19.78₹28.62₹21.32
Equity Capital₹265.84₹225.95₹202.03₹182.56
Total Equity & Liabilities₹450.72₹397.57₹356.58₹342.68
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
2611.8
10
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 10
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
50.53
Neutral
ATR (14)
115.56
Neutral
STOCH(9,6)
51.97
Neutral
STOCH RSI (14)
30.85
Neutral
ADX(9)
19.59
Bullish
UO(9)
48.09
Neutral
ROC(12)
-3.18
Bearish
WillR(14)
-64.25
Neutral
Period
Simple value
Exponential vaue
5D
2594.4
2606.17
10D
2599.89
2613.01
20D
2655.02
2617.59
50D
2546.85
2676.88
100D
2281.12
0
Volume trend — traded volume by day
7 Aug0L
6 Aug0L
5 Aug0L
4 Aug0L
3 Aug0L
Average0L
Compare against other stocks
KWALITY PHARMACEUTICALS L Share Price
KWALITY PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

KWALITY PHARMACEUTICALS L Share Price FAQs